Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2011
07/06/2011EP1689775B1 GAG binding proteins
07/06/2011EP1587834B1 Uses of il-23 mammalian cytokine; related reagents
07/06/2011EP1317283B1 Tweak receptor agonists as anti-angiogenic agents
07/06/2011EP1228076B1 A substantially cell membrane impermeable compound and use thereof
07/06/2011EP1173484B1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
07/06/2011CN1875748B Application method of lactoferritin in food
07/06/2011CN1871022B Peptides and compounds that bind to a receptor
07/06/2011CN1838965B Drug for cancer therapy
07/06/2011CN1738900B Protein specific to pancreatic beta cells in islets of langerhans and applications thereof
07/06/2011CN102119214A Composition comprising in vitro expanded T-lymphocytes and vessel formation inhibitors suitable in the treatment of cancer
07/06/2011CN102119172A Recombinantly produced human factor VIII and IX
07/06/2011CN102119171A CDCA1 epitope peptides and vaccines containing the same
07/06/2011CN102119032A Improved cytokine design
07/06/2011CN102119031A Conditioned medium of liver progenitor cells
07/06/2011CN102119028A Amino alcohol derivatives for the treatment of demyelinating peripheral neuropathies
07/06/2011CN102119022A Pharmaceutical compositions
07/06/2011CN102115495A Preparation method and application of protein drug for collagen targeted therapy of hyperplastic scar
07/06/2011CN102115494A Tick antibacterial peptide, gene thereof and application of same
07/06/2011CN102114240A Application of medicament containing hirudin and cellosolve
07/06/2011CN102114239A Application of cell factor-super-antigen fusion protein in preparation of anti-cancer drugs
07/06/2011CN102114000A Co-feeding lipid nano-delivery system for medicine carrying
07/06/2011CN102113999A Novel multi-layer polysaccharide structure-modified liposome-encapsulated hemoglobin nano-capsule blood substitute
07/06/2011CN102113996A Oral formulations containing protein or peptide, and preparation method and application thereof
07/06/2011CN101648991B Small peptide C with antibacterial and antitumor functions and applications thereof
07/06/2011CN101580539B Polypeptide for inducing CD4<+>CD25<+> regulatory T cells and application
07/06/2011CN101181263B Treatment of respiratory diseases
07/05/2011US7973151 Nucleic acid encoding modified human thymic stromal lymphopoietin
07/05/2011US7973150 Reducing the immunogenicity of fusion proteins
07/05/2011US7973143 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
07/05/2011US7973137 Cell compositions comprising molecular complexes that modify immune responses
07/05/2011US7973135 Compositions and methods for targeting cancer-specific transcription complexes
07/05/2011US7973128 Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof
07/05/2011US7973081 Emulsion compositions containing quaternary ammonium compounds
07/05/2011US7973064 Administering to a mammal therapeutically effective amount of opiate analgesic and endothelin antagonist for therapy and prophylaxis of pain
07/05/2011US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
07/05/2011US7973017 For treatment of endocrine-regulated tumors, for example, breast, prostate, ovarian and colon cancers
07/05/2011US7973011 Blockade of gamma-secretase activity to promote myelination by oligodendrocytes
07/05/2011US7973010 Full length polynucleotide coding chicken type II collagen and the use of it
07/05/2011US7973009 Methods and compositions for the prevention and treatment of anemia
07/05/2011US7973008 Metal-binding compounds and uses therefor
07/05/2011US7973007 Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration
07/05/2011US7973006 Antibacterial agent based on fatty acid esters of hydroxy carboxylic acid acids
07/05/2011US7973005 Alpha-1 antitrypsin for treating exacerbation episodes of pulmonary diseases
07/05/2011US7972848 Isolation and identification of cross-reactive T cells
07/05/2011US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse
07/05/2011US7972844 Nuclear factor κB inducing factor
07/05/2011US7972830 Thermostable Taq polymerase fragment
07/05/2011US7972829 Process for producing transglutaminase
07/05/2011US7972827 Photoswitchable method for the ordered attachment of proteins to surfaces
07/05/2011US7972821 Production of functional proteins: balance of shear stress and gravity
07/05/2011US7972815 Method of producing sugar chain using human G4 polypeptide
07/05/2011US7972814 Antimicrobial polypeptides from Pseudoplectania nigrella
07/05/2011US7972808 Digesting polypeptide mixture with proline-specific endoprotease and tripeptidase; recovering tripeptide products
07/05/2011US7972798 Method for identifying diabetic patients at increased risk for pathological complications
07/05/2011US7972797 Compositions and methods for the diagnosis and treatment of immune disorders
07/05/2011US7972788 Skin aging marker and technique for use thereof
07/05/2011US7972782 Steroid-activated nuclear receptors and uses therefor
07/05/2011US7972777 Nucleic acid probe-based diagnostic assays targeting ssrA genes of prokaryotic and eukaryotic organisms
07/05/2011US7972774 Methods of diagnosing cervical cancer
07/05/2011US7972771 Human brain carboxypeptidase B
07/05/2011US7972633 Nutritional supplements for healthy memory and mental function
07/05/2011US7972630 Injectable bone mineral substitute material
07/05/2011US7972629 Product comprising a combination of milk serum apoproteins and free fatty acids
07/05/2011US7972621 Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
07/05/2011US7972615 Peptide compositions for coating metal medical devices with vancomycin
07/05/2011US7972606 T24 antigen for immunodiagnosis of Taenia solium cysticercosis
07/05/2011US7972603 Stable immunogenic product comprising antigenic heterocomplexes
07/05/2011US7972598 VEGF-binding fusion proteins and therapeutic uses thereof
07/05/2011US7972595 Methods and compositions for protecting and treating at least one muscarinic receptor from dysfunction not resulting from oxidative stress, toxic actions of metals or infectious agents by administering a pyrophosphate analog
07/05/2011US7972593 Delivery of therapeutic agents to the bone
07/05/2011US7972591 Methods for treating rheumatoid arthritis and multiple sclerosis using MCP1 fusions
07/05/2011DE202011004857U1 Arznei- oder Nahrungsergänzungsmittel zur Behandlung und/oder Prophylaxe von Knochenerkrankungen Medicinal or dietary supplement for the treatment and / or prophylaxis of bone disease
07/05/2011CA2526754C Composition and foods for lowering glycemic index
07/05/2011CA2488630C Immunoadhesin comprising a glycoprotein vi domain
07/05/2011CA2451866C Nutritional composition preventing bacterial overgrowth
07/05/2011CA2446971C Use of 3-position cyclosporin derivatives for hair growth
07/05/2011CA2446136C Pyruvate derivatives
07/05/2011CA2440160C Antitumor compositions containing taxane derivatives
07/05/2011CA2439099C Anti-platelet and anti-thrombotic agents
07/05/2011CA2427475C Purification of hbv antigens for use in vaccines
07/05/2011CA2405767C Pharmaceutical formulations for dry powder inhalers
07/05/2011CA2390081C Modified viral surface proteins which bind to cells of tumor vasculature
07/05/2011CA2380066C Antitumor antibodies, proteins, and uses thereof
07/05/2011CA2374681C Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection
07/05/2011CA2358423C A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance
07/05/2011CA2345027C Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
07/05/2011CA2190290C A method of inducing an immune response using vaccinia virus recombinants
06/2011
06/30/2011WO2011079293A1 Tumor necrosis factor-related apoptosis inducing ligand polypeptides and their uses
06/30/2011WO2011079175A1 Compositions and methods for the treatment of angiogenesis-related eye diseases
06/30/2011WO2011079047A1 Methods for reducing the occurrence of preterm delivery and other pregnancy-related conditions
06/30/2011WO2011079015A1 Rgd-containing cyclic peptides
06/30/2011WO2011078990A1 Hydrogels comprising hyaluronan and at least one t cell induction agent
06/30/2011WO2011078893A1 Derivatives of apf and methods of use
06/30/2011WO2011078782A1 A composition comprising of melphalan derivatives and gemcitabine or etoposide useful in the treatment of cancer
06/30/2011WO2011078426A1 Peptide for suppressing and treating obesity
06/30/2011WO2011077701A1 Anti-androgenic agent, sebum secretion blocker, hair growth stimulant, and food or beverage
06/30/2011WO2011077402A2 Amphiphilic polymer functionalised by methionine
06/30/2011WO2011077359A2 Synergic action of a prolyl protease and tripeptidyl proteases
06/30/2011WO2011077133A2 Method of treatment and screening method
06/30/2011WO2011076903A1 Mutant nisin ser 29 derivatives and the use thereof